Roth MKM analyst Darren Aftahi raised the firm’s price target on Veritone to $12 from $10 and keeps a Buy rating on the shares ahead of its Q4 results. The company’s initiatives to control costs and focus on commercial AI growth have seen shares begin to rebound, the analyst tells investors in a research note. The firm adds that the customer cross-selling remains an untapped revenue stream for Veritone, which along with easing PandoLogic comps keep its outlook favorable.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on VERI: